Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9J37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,715
Award facts
- Contract value 100% obligated
- $18,714.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,714.71 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg dose in 2 mL pen format on November 25, 2025. This is a firm fixed-price, competitively awarded delivery order with a completion date of November 26, 2025. The award was issued without a set-aside designation, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor in the federal medical supply chain, particularly supporting military and veteran healthcare systems through the DLA's medical procurement network.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates AmerisourceBergen's extensive capability to meet federal procurement requirements through open competition and reflects the company's role in the DLA's pharmaceutical supply chain serving defense and military medical needs.
Quick answers
Who was awarded contract SPE2DR26F9J37?
SPE2DR26F9J37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F9J37 worth?
The government has obligated $18,715 on SPE2DR26F9J37.
Is contract SPE2DR26F9J37 an order under another contract?
Yes. SPE2DR26F9J37 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9J37 competed?
The extent of competition for SPE2DR26F9J37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award